摘要
背景:遗忘MCI(aMCI)在中国上海显着增加。 目的:本研究旨在评估aMCI的发病率和发病率,并确定上海社区≥60岁和≥70岁的aMCI的风险和保护因素。 方法:我们进行了这项为期1年的纵向研究,调查1,302个≥60岁的随机样本,通过自我报告收集有关生活方式的基线和随访数据,以及从医疗记录和血管和合并症状体检。我们还分析了≥70岁的个人亚组。 结果:≥60岁的aMCI患病率为22.3%,发病率(每1000人年)为96.9。是女性是aMCI的危险因素;保护因素包括吸烟,喝茶,退休前从事智力工作,社交活动和爱好,定期阅读习惯和上网冲浪。 aMCI在≥70岁人群中的发病率为30.3%,发病率为145.6。吸烟,喝茶和上网冲浪不是这个年龄组(≥70岁)的保护因素。 结论:本研究表明,aMCI在上海是一个相当大的健康问题。需要aMCI的预防策略来增强促进大脑活动的生活方式因素。
关键词: 记忆性轻度认知障碍,发生率,优势比,保护因素,患病率,危险因素。
Current Alzheimer Research
Title:Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai
Volume: 14 Issue: 4
关键词: 记忆性轻度认知障碍,发生率,优势比,保护因素,患病率,危险因素。
摘要: Background: Amnestic MCI (aMCI) has notably increased in Shanghai, China.
Objective: The study was designed to estimate the prevalence and incidence rates of aMCI and to determine the risk and protective factors for aMCI among persons ≥ 60 years-old and ≥ 70 years-old in Shanghai communities, respectively. Method: We carried out this 1-year longitudinal study to survey a random sample of 1,302 individuals ≥ 60 years-old, to collect baseline and follow-up data about lifestyle through self-reports, and vascular and comorbid conditions from medical records and a physical examination. We also analyzed a subgroup of individuals ≥ 70 years-old. Results: The prevalence rate of aMCI in persons ≥ 60 years-old was 22.3%, and the incidence rate (per 1,000 person-years) was 96.9. Being female was a risk factor for aMCI; protective factors included smoking, drinking tea, engaging in intellectual work before retirement, social activities and hobbies, regular reading habits, and surfing the internet. The prevalence rate of aMCI in persons ≥ 70 years was 30.3%, and the incidence rate was 145.6. Smoking, drinking tea, and surfing the internet were not protective factors for this age group (≥ 70 years). Conclusion: The present study indicates that aMCI is a considerable health problem in Shanghai. Preventive strategies for aMCI are needed to enhance lifestyle factors that promote brain activity.Export Options
About this article
Cite this article as:
Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai, Current Alzheimer Research 2017; 14 (4) . https://dx.doi.org/10.2174/1567205013666161122094208
DOI https://dx.doi.org/10.2174/1567205013666161122094208 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy
Current Drug Targets The Entirely Subcutaneous Defibrillator (S-Icd): State of the Art and Selection of the Ideal Candidate
Current Cardiology Reviews On the Analysis of Fingertip Photoplethysmogram Signals
Current Cardiology Reviews G-Protein Coupled Receptors (GPCRs): A Comprehensive Computational Perspective
Combinatorial Chemistry & High Throughput Screening Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72
Current Immunology Reviews (Discontinued) Cytokines as Regulators of Atherosclerosis in Murine Models
Current Drug Targets The Role of Infection in Carotid Plaque Pathogenesis and Stability: The Clinical Evidence
Current Vascular Pharmacology Editorial (Hot Topic:Current Situation at Perioperative of Cardiovascular Disease Patients: New Addressing and Perioperative Optimization Techniques)
Current Pharmaceutical Design Subject Index to Volume 1
Current Pharmacogenomics Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
Current Angiogenesis (Discontinued) Lipoprotein Lipase and Atherosclerosis
Current Vascular Pharmacology Editorial [Hot Topic: Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews The Effects of Drugs Used in Anaesthesia on Platelet Membrane Receptors and on Platelet Function
Current Drug Targets Biologic Therapies in Primary Sjögren's Syndrome
Current Pharmaceutical Biotechnology Pulmonary Arterial Hypertension
Current Vascular Pharmacology Patent Selections
Recent Patents on Cardiovascular Drug Discovery Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes
Current Pharmaceutical Design